Spironolactone Tablet, Film Coated
Product Images NDC 43063-832

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 43063-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063832 Label (43063832)

Label for Spironolactone USP 25 mg oral film-coated tablets, containing 30 tablets per bottle. The label displays the NDC number 43063-832-30, manufacturer PD-Rx Pharmaceuticals, Inc., and batch information including lot E20D43 and expiration date 08/2021. The label includes warnings to keep out of reach of children and instructions for dosage and storage.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)

A line graph comparing the probability over time in months between spironolactone and placebo groups. The spironolactone group is represented by a dashed line with a higher probability trend, while the placebo group is shown with a solid line, indicating a lower probability trend. The graph includes sample sizes for each group (spironolactone n=822, placebo n=841) and a log-rank p-value less than 0.001.*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)

A forest plot illustrating hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone versus placebo. Subgroups displayed include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium level, digoxin, ACE inhibitor and beta blocker use. The plot shows HR values with a vertical line dividing spironolactone better from placebo better outcomes.*

FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical structure diagram of spironolactone, showing its steroidal core with attached functional groups including a lactone ring and a thioacetyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.